Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07780643 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1)

Name: A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-1) — clinical trial record (NCT07780643)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorGlaxoSmithKline

Started2026-08-31

View on ClinicalTrials.gov ↗

The study aims to demonstrate the superiority of GSK5784283 compared to placebo in reducing the annualized rate of clinically meaningful asthma exacerbations.

Trial Details

NCT Number	NCT07780643
Lead Sponsor	GlaxoSmithKline
Conditions	Asthma
Enrollment	514 participants
Start Date	2026-08-31
Primary Completion	2029-02-15 (estimated)
Study Completion	2029-10-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-21